These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Chronic urticaria serum induces histamine release, leukotriene production, and basophil CD63 surface expression--inhibitory effects ofanti-inflammatory drugs. Wedi B; Novacovic V; Koerner M; Kapp A J Allergy Clin Immunol; 2000 Mar; 105(3):552-60. PubMed ID: 10719307 [TBL] [Abstract][Full Text] [Related]
5. Secretion of cytokines, histamine and leukotrienes in chronic urticaria. Ferrer M; Luquin E; Sanchez-Ibarrola A; Moreno C; Sanz ML; Kaplan AP Int Arch Allergy Immunol; 2002 Nov; 129(3):254-60. PubMed ID: 12444324 [TBL] [Abstract][Full Text] [Related]
6. Assessment of histamine-releasing activity of sera from patients with chronic urticaria showing positive autologous skin test on human basophils and mast cells. Asero R; Lorini M; Chong SU; Zuberbier T; Tedeschi A Clin Exp Allergy; 2004 Jul; 34(7):1111-4. PubMed ID: 15248858 [TBL] [Abstract][Full Text] [Related]
10. Activated status of basophils in chronic urticaria leads to interleukin-3 hyper-responsiveness and enhancement of histamine release induced by anti-IgE stimulus. Lourenço FD; Azor MH; Santos JC; Prearo E; Maruta CW; Rivitti EA; Duarte AJ; Sato MN Br J Dermatol; 2008 May; 158(5):979-86. PubMed ID: 18341658 [TBL] [Abstract][Full Text] [Related]
11. Validation of basophil histamine release against the autologous serum skin test and outcome of serum-induced basophil histamine release studies in a large population of chronic urticaria patients. Platzer MH; Grattan CE; Poulsen LK; Skov PS Allergy; 2005 Sep; 60(9):1152-6. PubMed ID: 16076300 [TBL] [Abstract][Full Text] [Related]
12. Plasma levels of matrix metalloproteinase-9 in chronic urticaria patients correlate with disease severity and C-reactive protein but not with circulating histamine-releasing factors. Tedeschi A; Asero R; Lorini M; Marzano AV; Cugno M Clin Exp Allergy; 2010 Jun; 40(6):875-81. PubMed ID: 20214668 [TBL] [Abstract][Full Text] [Related]
14. Increased compound 48/80 induced local histamine release from nonlesional skin of patients with chronic urticaria. Bédard PM; Brunet C; Pelletier G; Hébert J J Allergy Clin Immunol; 1986 Dec; 78(6):1121-5. PubMed ID: 2431027 [TBL] [Abstract][Full Text] [Related]
15. Autoreactivity is highly prevalent in patients with multiple intolerances to NSAIDs. Asero R; Tedeschi A; Lorini M Ann Allergy Asthma Immunol; 2002 May; 88(5):468-72. PubMed ID: 12027067 [TBL] [Abstract][Full Text] [Related]
16. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. Hide M; Francis DM; Grattan CE; Hakimi J; Kochan JP; Greaves MW N Engl J Med; 1993 Jun; 328(22):1599-604. PubMed ID: 7683772 [TBL] [Abstract][Full Text] [Related]
17. Comparison of serum histamine-releasing activity and clinical manifestations in chronic idiopathic urticaria. Tanus T; Atkins PC; Zweiman B Clin Diagn Lab Immunol; 1996 Jan; 3(1):135-7. PubMed ID: 8770518 [TBL] [Abstract][Full Text] [Related]
18. Spontaneous release of histamine from basophils and histamine-releasing factor in patients with atopic dermatitis and food hypersensitivity. Sampson HA; Broadbent KR; Bernhisel-Broadbent J N Engl J Med; 1989 Jul; 321(4):228-32. PubMed ID: 2473400 [TBL] [Abstract][Full Text] [Related]
19. Circulating stem cell factor in patients with chronic idiopathic urticaria. Asero R; Tedeschi A; Lorini M; Gerosa M; Meroni P; Riboldi P Ann Allergy Asthma Immunol; 2003 Jul; 91(1):79-81. PubMed ID: 12877454 [TBL] [Abstract][Full Text] [Related]